NewAmsterdam Pharma

Last updated: September 15, 2024

Michael Davidson – CEO
Michael Davidson – CEO
Netherlands | Funding: $786.3M (+)

Website: https://www.newamsterdampharma.com/

Founded is a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases